|
[1]
|
Rouzbahman, M. and Chetty, R. (2013) Mucinous Tumours of Appendix and Ovary: An Overview and Evaluation of Current Practice. Journal of Clinical Pathology, 67, 193-197. [Google Scholar] [CrossRef] [PubMed]
|
|
[2]
|
Li, X., Zhou, J., Dong, M. and Yang, L. (2018) Management and Prognosis of Low-Grade Appendiceal Mucinous Neoplasms: A Clinicopathologic Analysis of 50 Cases. European Journal of Surgical Oncology, 44, 1640-1645. [Google Scholar] [CrossRef] [PubMed]
|
|
[3]
|
Umetsu, S.E. and Kakar, S. (2023) Staging of Appendiceal Mucinous Neoplasms: Challenges and Recent Updates. Human Pathology, 132, 65-76. [Google Scholar] [CrossRef] [PubMed]
|
|
[4]
|
Lu, Z. and Chen, J. (2014) [Introduction of WHO Classification of Tumours of Female Reproductive Organs, Fourth Edition]. Chinese Journal of Pathology, 43, 649-650.
|
|
[5]
|
Shih, I. and Kurman, R.J. (2004) Ovarian Tumorigenesis: A Proposed Model Based on Morphological and Molecular Genetic Analysis. The American Journal of Pathology, 164, 1511-1518. [Google Scholar] [CrossRef] [PubMed]
|
|
[6]
|
解建军. 阑尾低级别黏液性肿瘤卵巢转移形态及免疫组织化学诊断研究[M]. 青岛: 卫生医药科技, 2022.
|
|
[7]
|
Lertkhachonsuk, A., Buranawongtrakoon, S., Lekskul, N., Rermluk, N., Wee‐Stekly, W. and Charakorn, C. (2020) Serum CA19‐9, CA‐125 and CEA as Tumor Markers for Mucinous Ovarian Tumors. Journal of Obstetrics and Gynaecology Research, 46, 2287-2291. [Google Scholar] [CrossRef] [PubMed]
|
|
[8]
|
林怡婷.不同手术方式治疗卵巢良性及交界性粘液性肿瘤的临床疗效及预后分析[D]: [硕士学位论文]. 福州: 福建医科大学, 2021.
|
|
[9]
|
Solomon, D., Bekhor, E., Leigh, N., Maniar, Y.M., Totin, L., Hofstedt, M., et al. (2019) Surveillance of Low-Grade Appendiceal Mucinous Neoplasms with Peritoneal Metastases after Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: Are 5 Years Enough? A Multisite Experience. Annals of Surgical Oncology, 27, 147-153. [Google Scholar] [CrossRef] [PubMed]
|
|
[10]
|
张琪, 汤东, 周家杰, 等. 低级别阑尾黏液性肿瘤58例临床分析[J]. 中国实用外科杂志, 2024, 44(5): 583-587, 593.
|
|
[11]
|
Ricci, F., Affatato, R., Carrassa, L. and Damia, G. (2018) Recent Insights into Mucinous Ovarian Carcinoma. International Journal of Molecular Sciences, 19, Article 1569. [Google Scholar] [CrossRef] [PubMed]
|
|
[12]
|
Saga, Y. (2012) Cetuximab Inhibits the Growth of Mucinous Ovarian Carcinoma Tumor Cells Lacking KRAS Gene Mutations. Oncology Reports, 27, 1336-1340. [Google Scholar] [CrossRef] [PubMed]
|
|
[13]
|
McAlpine, J.N., Wiegand, K.C., Vang, R., Ronnett, B.M., Adamiak, A., Köbel, M., et al. (2009) HER2 Overexpression and Amplification Is Present in a Subset of Ovarian Mucinous Carcinomas and Can Be Targeted with Trastuzumab Therapy. BMC Cancer, 9, Article No. 433. [Google Scholar] [CrossRef] [PubMed]
|
|
[14]
|
Bhatt, A. and Glehen, O. (2016) The Role of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Ovarian Cancer: A Review. Indian Journal of Surgical Oncology, 7, 188-197. [Google Scholar] [CrossRef] [PubMed]
|